Editors
Editor-in-Chief
Daiming Fan, M.D, China Anti-Cancer Association, Xijing Hospital of Digestive Diseases, China
Honorary Editor-in-Chief
Harald Z. Hausen†, M.D, D.Sc. (Hon), M.D.s (Hon), German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Germany
Associate Editor-in-Chief
Rene Bernards, Ph.D, The Netherlands Cancer Institute, Netherlands
Yihai Cao, M.D, Ph.D, Karolinska Institutet, Sweden
Webster K. Cavenee, Ph.D, University of California San Diego, USA
Eduardo L Cazap, M.D, Ph.D, FASCO, Latin-American & Caribbean Society of Medical Oncology, Argentina
Mauricio M. Costa, M.D, Ph.D, National Academy of Medicine, Brazil
Raju Kucherlapati, Ph.D, Harvard Medical School, USA
Barry J. Marshall, FRACP, FAA, FRS, MBBS, The University of Western Australia, Australia
Cunyu Wang, D.D.S., Ph.D, University of California Los Angeles, USA
Hongyang Wang, Ph.D, The National Center for Liver Cancer, China
Yuzhuo Wang, Ph.D, Department of Experimental Therapeutics, BC Cancer; Department of Experimental Therapeutics, BC Cancer; Vancouver Prostate Centre, Vancouver General Hospital, Canada
Qimin Zhan, Ph.D, Peking University Shenzhen Graduate School, China
Executive Associate Editor-in-Chief
Ying Wang, M.D, China Anti-Cancer Association, China
Editorial Board Member
Matti Aapro, M.D, Clinique de Genolier, Switzerland
Gamal M. A. Amira, M.D, Ph.D, National Cancer Institute Cairo University, Egypt
Partha Basu, Ph.D, M.Sc, B.Sc, World Health Organization, France
Yazid Belkacemi, Ph.D, Henri Mondor University Hospital and University of Paris East Creteil (UPEC), France
Simona Borstnar, M.D, PhD, Division of Medical Oncology, Slovenia
Daniel J. Campos, M.D, Clinical Research Institute Latin American & Caribbean Society of Medical Oncology, Argentina
Wanqing Chen, Ph.D, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, China
David C. Christiani, M.D, MPH, M.S, Harvard Medical School; Harvard T.H. Chan School of Public Health, USA
Chan Hon Chui, MBBS, FRCS, FAMS, Mount Elizabeth Medical Centre, Singapore
Anil D. Cruze, M.S, DNB. FRCS (Hon), Uion for International Cancer Control (UICC), India
Shuzhong Cui, M.D, Ph.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, China
Hiroyuki Daiko, M.D, Ph.D, FACS, Esophageal Surgery Division, Japan
Csaba L. Dégi, Ph.D, Babeș – Bolyai University, Romania
Emad M El-Omar, BSc (Hons), MBChB, M.D (Hons), FRCP (Edin), FRSE, FRACP, University of New South Wales, Australia
Saijun Fan, Ph.D, Institute of Radiation Medicine Chinese Academy of Medical Sciences, China
Wentao Fang, M.D, Shanghai Chest hospital, China
Eduardo L. Franco, DrPH, PhD (Hon.), O.C., FRSC, FCAHS, McGill University, Canada
Vanessa Fuchs, M.D, PHD, R.D, Hospital General de México, Mexico
Hengjun Gao, Ph.D, Shanghai Biochip National Engineering Research Center, China
Mary K. Gospodarowicz, M.D, FRCPC, FRCR (Hon), Princess Margaret Cancer Centre – University of Toronto, Canada
Jian Gu, Ph.D, The University of Texas MD Anderson Cancer Center, USA
Wei Guo, M.D, Shanghai 9th People’s Hospital, Shanghai Jiao Tong University, China
Xiaomao Guo, M.D, Fudan University Shanghai Cancer Center, China
Jie He, Ph.D, Cancer Hospital Chinese Academy of Medical Sciences, China
Thorsten Heilmann, M.D, Niels-Stensen-Kliniken Franziskus-Hospital Harderberg, Germany
William Ying Khee Hwang, MBBS, MMed, FRCP, FAMS, MBA, National Cancer Centre Singapore, Singapore
Xichun Hu, M.D, Ph.D, Fudan University Shanghai Cancer Center, China
Xiaojun Huang, M.D, Peking University Institute of Hematology , China
Norihiko Ikeda, M.D, Ph.D, Tokyo Medical University, Japan
Jiafu Ji, Ph.D, Peking University Cancer Hospital, China
Le Jian, M.D, Ph.D, Curtin University, Australia
Henrik Jørn Ditzel, MD, PhD, DMSc, Odense University Hospital, University of Southern Denmark, Denmark
Jae-Weon Kim, M.D, Ph.D, Seoul National University & Seoul National University Hospital, Korea
Nikola Korpan, M.D, Ph.D, International Institute of Cryosurgery,National Medical University, Austria
Tibor Kovacs, M.D, Ph.D, FRCS, FEBS, Guy’s Hospital London-King’s College London, UK
Tezer Kutluk, M.D, Ph.D, FAA, Hacettepe University Medical School and Cancer Institute, Turkey
Maria Pilar Laguna, M.D, Ph.D, Istanbul Medipol University, Turkey
Changling Li, M.D, Cancer Hospital Chinese Academy of Medical Sciences, China
Min Li, Ph.D, University of Oklahoma Health Sciences Center, USA
Qiang Li, M.D, Tianjin Medical University Cancer Institute & Hospital, China
Anne Wing Mui Lee, M.D, The University of Hong Kong, China
Han Liang, M.D, Tianjin Medical University Cancer Institute & Hospital, China
Han Liang, Ph.D, The University of Texas MD Anderson Cancer Center, USA
Zhen Lin, Ph.D, School of Medicine, Western Sydney University, Australia
Aiyi Liu, Ph.D, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA
Yaping Liu, Ph.D, Australasian College of Health Service Management, Australia
Zhijie Liu, Ph.D, Mays Cancer Center, University of Texas Health Science Center at San Antonio, USA
Wei Lu, Ph.D, Tianjin Medical University Cancer Institute & Hospital, China
Changhong Miao, M.D, Zhongshan Hospital,Fudan University, China
JunEtsu Mizoe, M.D, Ph.D, Hokkaido Ohno Memorial Hospital, Japan
Corazon A. Ngelangel, M.S, M.D, Ph.D, Asian Cancer Institute, Asian Hospital and Medical Center, Muntinlupa City, Philippines, Philippines
Lydia Ioannidou-Mouzaka, M.D, Ph.D, Medical School - University of Athens, Greece
Ruben Orda, M.D, M.S, FACS, International Society of Senology (SIS), Israel
Kenichi Oyama, M.D, Ph.D, International University of Health & Welfare Mita Hospital, Japan
Haozhe Piao, M.D, Liaoning Cancer Hospital & Institute, China
Robert Pirker, M.D, Private Practice Internal Medicine (Hemato-Oncology), Austria
Danielle Rodin, M.D, MPH, FRCPC, Princess Margaret Cancer Centre, Canada
Rafael Rosell, M.D, Ph.D, IOR, Quirón-Dexeus University Institute, Barcelona, Spain
Gustavo Sarria. M.D, National Institute of Neoplastic Disease, Peru
Schlomo Schneebaum, Tel Aviv University, Tel Aviv, Israel
Vladislav Semiglazov, Ph.D, N.N. Petrov National Medical Research Center of Oncology, Russia
Zhimin Shao, Master, Fudan University Shanghai Cancer Center, China
Hongbing Shen, Ph.D, Nanjing Medical University, China
Hanping Shi, Ph.D, M.D, FACS, Beijing Shijitan Hospital, Capital Medical University, China
Yogendra P. Singh, M.D, Ph.D, Tribhuvan University Teaching Hospital/Institute of Medicine Nepal
Marek Smolár, M.D, Ph.D, MPH, University Hospital Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
Shunichi Takeda, Ph.D, Kyoto University, Medical School, Japan
Dongfeng Tan, M.D, The University of Texas MD Anderson Cancer Center, USA
Yongmin, Tang, M.D, Children’s Hospital of Zhejiang University School of Medicine, China
Yantao Tian, Ph.D, Cancer Hospital Chinese Academy of Medical Sciences, China
Jiping Wang, M.D, Ph.D, Brigham and Women’s Hospital, Harvard Medical School, USA
Xiaoju Wang, Ph.D, The University of Michigan, USA
Shelly Xin Wang, M.D, MPH, The University of Texas MD Anderson Cancer Center, USA
Xishan Wang, M.D, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, China
Qingyi Wei, M.D, Ph.D, Duke University School of Medicine, USA
Wenbin Wei, M.D, Beijing Tongren Hospital, China
Jiong Wu, Ph.D, Fudan University Shanghai Cancer Center, China
Ming Wu, M.D, Peiking Union Medical College Hospital, Chinese Academy of Medical Sciences, China
Yongzhong Wu, Ph.D, Chongqing University Cancer Hospital, China
Jinliang Xing, Ph.D, Air Force Military Medical University, China
Mingzhao Xing, M.D, Ph.D, The Johns Hopkins University School of Medicine, USA
Liang Xu, M.D, Ph.D, University of Kansas, USA
Ruihua Xu, M.D, Ph.D, Sun Yat-sen University Cancer Center, China
Li Yan, Ph.D, Brii Biosciences; US Chinese Anti-Cancer Association, USA
Xuexian Yan, M.D, Singapore General Hospital, Singapore
Han-Kwang Yang, M.D, Ph.D, Seoul National University Hospital & Seoul National University College of Medicine, Korea
Jianbo Yang, Ph.D, University of Minnesota, USA
Peiying Yang, Ph.D, The University of Texas MD Anderson Cancer Center, USA
Kazuhiro Yoshida, Ph.D, Gifu University, Japan
Jinming Yu, Ph.D, Shandong Cancer Hospital and Institute, China
Jun Yu, Ph.D, The Johns Hopkins University School of Medicine, USA
Xianjun Yu, M.D, Ph.D, Fudan University Shanghai Cancer Center, China
Xueqin Yu, Ph.D, The University of Sydney, a joint venture with Cancer Council NSW, Australia
Jiangong Zhang, Master, Affiliated Cancer Hospital of Zhengzhou University, China
Wei Zhang, Ph.D, Wake Forest Comprehensive Cancer Center, USA
Xiao Zhou, Master, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, China
Daiming Fan, M.D, China Anti-Cancer Association, Xijing Hospital of Digestive Diseases, China
Honorary Editor-in-Chief
Harald Z. Hausen†, M.D, D.Sc. (Hon), M.D.s (Hon), German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Germany
Associate Editor-in-Chief
Rene Bernards, Ph.D, The Netherlands Cancer Institute, Netherlands
Yihai Cao, M.D, Ph.D, Karolinska Institutet, Sweden
Webster K. Cavenee, Ph.D, University of California San Diego, USA
Eduardo L Cazap, M.D, Ph.D, FASCO, Latin-American & Caribbean Society of Medical Oncology, Argentina
Mauricio M. Costa, M.D, Ph.D, National Academy of Medicine, Brazil
Raju Kucherlapati, Ph.D, Harvard Medical School, USA
Barry J. Marshall, FRACP, FAA, FRS, MBBS, The University of Western Australia, Australia
Cunyu Wang, D.D.S., Ph.D, University of California Los Angeles, USA
Hongyang Wang, Ph.D, The National Center for Liver Cancer, China
Yuzhuo Wang, Ph.D, Department of Experimental Therapeutics, BC Cancer; Department of Experimental Therapeutics, BC Cancer; Vancouver Prostate Centre, Vancouver General Hospital, Canada
Qimin Zhan, Ph.D, Peking University Shenzhen Graduate School, China
Executive Associate Editor-in-Chief
Ying Wang, M.D, China Anti-Cancer Association, China
Editorial Board Member
Matti Aapro, M.D, Clinique de Genolier, Switzerland
Gamal M. A. Amira, M.D, Ph.D, National Cancer Institute Cairo University, Egypt
Partha Basu, Ph.D, M.Sc, B.Sc, World Health Organization, France
Yazid Belkacemi, Ph.D, Henri Mondor University Hospital and University of Paris East Creteil (UPEC), France
Simona Borstnar, M.D, PhD, Division of Medical Oncology, Slovenia
Daniel J. Campos, M.D, Clinical Research Institute Latin American & Caribbean Society of Medical Oncology, Argentina
Wanqing Chen, Ph.D, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, China
David C. Christiani, M.D, MPH, M.S, Harvard Medical School; Harvard T.H. Chan School of Public Health, USA
Chan Hon Chui, MBBS, FRCS, FAMS, Mount Elizabeth Medical Centre, Singapore
Anil D. Cruze, M.S, DNB. FRCS (Hon), Uion for International Cancer Control (UICC), India
Shuzhong Cui, M.D, Ph.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, China
Hiroyuki Daiko, M.D, Ph.D, FACS, Esophageal Surgery Division, Japan
Csaba L. Dégi, Ph.D, Babeș – Bolyai University, Romania
Emad M El-Omar, BSc (Hons), MBChB, M.D (Hons), FRCP (Edin), FRSE, FRACP, University of New South Wales, Australia
Saijun Fan, Ph.D, Institute of Radiation Medicine Chinese Academy of Medical Sciences, China
Wentao Fang, M.D, Shanghai Chest hospital, China
Eduardo L. Franco, DrPH, PhD (Hon.), O.C., FRSC, FCAHS, McGill University, Canada
Vanessa Fuchs, M.D, PHD, R.D, Hospital General de México, Mexico
Hengjun Gao, Ph.D, Shanghai Biochip National Engineering Research Center, China
Mary K. Gospodarowicz, M.D, FRCPC, FRCR (Hon), Princess Margaret Cancer Centre – University of Toronto, Canada
Jian Gu, Ph.D, The University of Texas MD Anderson Cancer Center, USA
Wei Guo, M.D, Shanghai 9th People’s Hospital, Shanghai Jiao Tong University, China
Xiaomao Guo, M.D, Fudan University Shanghai Cancer Center, China
Jie He, Ph.D, Cancer Hospital Chinese Academy of Medical Sciences, China
Thorsten Heilmann, M.D, Niels-Stensen-Kliniken Franziskus-Hospital Harderberg, Germany
William Ying Khee Hwang, MBBS, MMed, FRCP, FAMS, MBA, National Cancer Centre Singapore, Singapore
Xichun Hu, M.D, Ph.D, Fudan University Shanghai Cancer Center, China
Xiaojun Huang, M.D, Peking University Institute of Hematology , China
Norihiko Ikeda, M.D, Ph.D, Tokyo Medical University, Japan
Jiafu Ji, Ph.D, Peking University Cancer Hospital, China
Le Jian, M.D, Ph.D, Curtin University, Australia
Henrik Jørn Ditzel, MD, PhD, DMSc, Odense University Hospital, University of Southern Denmark, Denmark
Jae-Weon Kim, M.D, Ph.D, Seoul National University & Seoul National University Hospital, Korea
Nikola Korpan, M.D, Ph.D, International Institute of Cryosurgery,National Medical University, Austria
Tibor Kovacs, M.D, Ph.D, FRCS, FEBS, Guy’s Hospital London-King’s College London, UK
Tezer Kutluk, M.D, Ph.D, FAA, Hacettepe University Medical School and Cancer Institute, Turkey
Maria Pilar Laguna, M.D, Ph.D, Istanbul Medipol University, Turkey
Changling Li, M.D, Cancer Hospital Chinese Academy of Medical Sciences, China
Min Li, Ph.D, University of Oklahoma Health Sciences Center, USA
Qiang Li, M.D, Tianjin Medical University Cancer Institute & Hospital, China
Anne Wing Mui Lee, M.D, The University of Hong Kong, China
Han Liang, M.D, Tianjin Medical University Cancer Institute & Hospital, China
Han Liang, Ph.D, The University of Texas MD Anderson Cancer Center, USA
Zhen Lin, Ph.D, School of Medicine, Western Sydney University, Australia
Aiyi Liu, Ph.D, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA
Yaping Liu, Ph.D, Australasian College of Health Service Management, Australia
Zhijie Liu, Ph.D, Mays Cancer Center, University of Texas Health Science Center at San Antonio, USA
Wei Lu, Ph.D, Tianjin Medical University Cancer Institute & Hospital, China
Changhong Miao, M.D, Zhongshan Hospital,Fudan University, China
JunEtsu Mizoe, M.D, Ph.D, Hokkaido Ohno Memorial Hospital, Japan
Corazon A. Ngelangel, M.S, M.D, Ph.D, Asian Cancer Institute, Asian Hospital and Medical Center, Muntinlupa City, Philippines, Philippines
Lydia Ioannidou-Mouzaka, M.D, Ph.D, Medical School - University of Athens, Greece
Ruben Orda, M.D, M.S, FACS, International Society of Senology (SIS), Israel
Kenichi Oyama, M.D, Ph.D, International University of Health & Welfare Mita Hospital, Japan
Haozhe Piao, M.D, Liaoning Cancer Hospital & Institute, China
Robert Pirker, M.D, Private Practice Internal Medicine (Hemato-Oncology), Austria
Danielle Rodin, M.D, MPH, FRCPC, Princess Margaret Cancer Centre, Canada
Rafael Rosell, M.D, Ph.D, IOR, Quirón-Dexeus University Institute, Barcelona, Spain
Gustavo Sarria. M.D, National Institute of Neoplastic Disease, Peru
Schlomo Schneebaum, Tel Aviv University, Tel Aviv, Israel
Vladislav Semiglazov, Ph.D, N.N. Petrov National Medical Research Center of Oncology, Russia
Zhimin Shao, Master, Fudan University Shanghai Cancer Center, China
Hongbing Shen, Ph.D, Nanjing Medical University, China
Hanping Shi, Ph.D, M.D, FACS, Beijing Shijitan Hospital, Capital Medical University, China
Yogendra P. Singh, M.D, Ph.D, Tribhuvan University Teaching Hospital/Institute of Medicine Nepal
Marek Smolár, M.D, Ph.D, MPH, University Hospital Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
Shunichi Takeda, Ph.D, Kyoto University, Medical School, Japan
Dongfeng Tan, M.D, The University of Texas MD Anderson Cancer Center, USA
Yongmin, Tang, M.D, Children’s Hospital of Zhejiang University School of Medicine, China
Yantao Tian, Ph.D, Cancer Hospital Chinese Academy of Medical Sciences, China
Jiping Wang, M.D, Ph.D, Brigham and Women’s Hospital, Harvard Medical School, USA
Xiaoju Wang, Ph.D, The University of Michigan, USA
Shelly Xin Wang, M.D, MPH, The University of Texas MD Anderson Cancer Center, USA
Xishan Wang, M.D, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, China
Qingyi Wei, M.D, Ph.D, Duke University School of Medicine, USA
Wenbin Wei, M.D, Beijing Tongren Hospital, China
Jiong Wu, Ph.D, Fudan University Shanghai Cancer Center, China
Ming Wu, M.D, Peiking Union Medical College Hospital, Chinese Academy of Medical Sciences, China
Yongzhong Wu, Ph.D, Chongqing University Cancer Hospital, China
Jinliang Xing, Ph.D, Air Force Military Medical University, China
Mingzhao Xing, M.D, Ph.D, The Johns Hopkins University School of Medicine, USA
Liang Xu, M.D, Ph.D, University of Kansas, USA
Ruihua Xu, M.D, Ph.D, Sun Yat-sen University Cancer Center, China
Li Yan, Ph.D, Brii Biosciences; US Chinese Anti-Cancer Association, USA
Xuexian Yan, M.D, Singapore General Hospital, Singapore
Han-Kwang Yang, M.D, Ph.D, Seoul National University Hospital & Seoul National University College of Medicine, Korea
Jianbo Yang, Ph.D, University of Minnesota, USA
Peiying Yang, Ph.D, The University of Texas MD Anderson Cancer Center, USA
Kazuhiro Yoshida, Ph.D, Gifu University, Japan
Jinming Yu, Ph.D, Shandong Cancer Hospital and Institute, China
Jun Yu, Ph.D, The Johns Hopkins University School of Medicine, USA
Xianjun Yu, M.D, Ph.D, Fudan University Shanghai Cancer Center, China
Xueqin Yu, Ph.D, The University of Sydney, a joint venture with Cancer Council NSW, Australia
Jiangong Zhang, Master, Affiliated Cancer Hospital of Zhengzhou University, China
Wei Zhang, Ph.D, Wake Forest Comprehensive Cancer Center, USA
Xiao Zhou, Master, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, China